Cargando…
Omega-3 fatty acid blood levels are inversely associated with cardiometabolic risk factors in HFpEF patients: the Aldo-DHF randomized controlled trial
OBJECTIVES: To evaluate associations of omega-3 fatty acid (O3-FA) blood levels with cardiometabolic risk markers, functional capacity and cardiac function/morphology in patients with heart failure with preserved ejection fraction (HFpEF). BACKGROUND: O3-FA have been linked to reduced risk for HF an...
Autores principales: | Lechner, Katharina, Scherr, Johannes, Lorenz, Elke, Lechner, Benjamin, Haller, Bernhard, Krannich, Alexander, Halle, Martin, Wachter, Rolf, Duvinage, André, Edelmann, Frank |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873063/ https://www.ncbi.nlm.nih.gov/pubmed/34453204 http://dx.doi.org/10.1007/s00392-021-01925-9 |
Ejemplares similares
-
Saturated Fatty Acid Blood Levels and Cardiometabolic Phenotype in Patients with HFpEF: A Secondary Analysis of the Aldo-DHF Trial
por: Lechner, Katharina, et al.
Publicado: (2022) -
Trans-fatty acid blood levels of industrial but not natural origin are associated with cardiovascular risk factors in patients with HFpEF: a secondary analysis of the Aldo-DHF trial
por: Lechner, Katharina, et al.
Publicado: (2023) -
De Novo Lipogenesis-Related Monounsaturated Fatty Acids in the Blood Are Associated with Cardiovascular Risk Factors in HFpEF Patients
por: Bock, Matthias, et al.
Publicado: (2023) -
Longitudinal association between N-terminal B-type natriuretic peptide, anxiety and social support in patients with HFpEF: results from the multicentre randomized controlled Aldo-DHF trial
por: Wilke, Marieke R., et al.
Publicado: (2023) -
Obesity and HFpEF
por: Clemenza, Francesco, et al.
Publicado: (2022)